We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Plant May Become Potent Drug for Cancer

By Biotechdaily staff writers
Posted on 28 Aug 2006
Researchers in Italy have found a way to increase the concentration of the natural chemotherapeutic agent glucobrassicin in the leaves of the woad plant, so that it may become commercially viable to isolate and purify this potentially useful drug.

Woad (Isatis tinctoria), which is related to members of the cabbage family such as broccoli and cauliflower, has been used for thousands of years as a source of indigo dye. More...
Additionally, it is rich in glucobrassicin, a compound released by the plant after injury to protect itself from insects and other pests. In humans, glucobrassicin has been shown to be effective in the treatment of breast cancer, probably through its ability to bind to and eliminate estrogen.

Investigators at the University of Bologna (Italy) reported in the August 14, 2006, online edition of the Journal of the Science of Food and Agriculture that artificial wounding of the leaves combined with fertilization of the plant increased the concentration of glucobrassicin by more than 30%. Cancer researchers are taking the potential for woad seriously. The group of drugs known as taxanes, for example, derived from yew, have been found to be a powerful form of chemotherapy and are now widely used in the treatment of ovarian and breast cancer.

First author Dr. Stefania Galletti, professor of experimental agriculture at the University of Bologna, said, "The crop cycle is very short since the treatment is performed on young plants, but it could be hypothetically repeated after the first collection of the newly formed leaves. The availability of glucobrassicin in good amounts and at low cost could finally permit studies to be performed in order to clarify the anti-cancer role of glucobrassicin-rich vegetables, like broccoli, in the human diet.”



Related Links:
University of Bologna

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Automatic CLIA Analyzer
Shine i6000
New
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.